Advice You - Business

Problem of Training Transfer

A new inventory system was installed in a typical manufacturing company. Employees in the Purchasing Department were sent off to learn how to use the new software. One month later, the Purchasing Manager finds that only two out of the twelve Pur

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

chasing Officers are using the new system. The expected cost savings have not materialized and the Purchasing Manager resolves to take issue with the Training Manager at the next weekly meeting.

Does this sound familiar? Experts estimate that somewhat less that twenty percent of training

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

investments lead to some organizational benefit. This anomaly is commonly referred to as the "problem of training transfer". Why is it that such a small proportion of training ends up being used back in the workplace? With increasing marketplace competition, leaner resources and a greater

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

focus on tangible outcomes, more and more managers are asking this question.

How can you increase the transfer of training in your organization? For any given training program, you will need to look into three areas: training participant attributes (intelligence, attitudes)<

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

li>
training program design and delivery

workplace environment

What can you do to enhance the positive impact of each of these factors? Looking at the first factor, training participant attributes may be influenced when introducing new employees to your or

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ganization through an effective recruitment, selection and induction process. Attributes can also be influenced before training begins through pre-qualifying nominees during the registration process.

The second factor, training design and delivery, can be made more effective through ensu

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ing that the training program objectives are clearly focused on your organization's priorities and goals. Tied in with this, participants’ learning outcomes must be stated in terms of behavior required in the workplace and measurable performance standards.

Along with effective design, in

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

order to maximize training transfer to the workplace ensure that the training is delivered in accordance with what we know about how adults learn best. However, it is the third area mentioned above, the employee's workplace environment, that is the most significant, yet most neglected, fa

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tor influencing the extent of training transfer. What happens before employees attend the training event and what happens after they return to work are the most important variables determining workplace performance following training.

The PRACTICE Approach

The vario

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

us attitudes and activities required by supervisors, managers and trainers for maximum transfer can be consolidated into an easy to remember and use model. I call this method the PRACTICE Approach ©. By focusing on each of the eight key elements, organizations can be confide

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

t of maximizing their training investments. These eight key elements of the PRACTICE Approach © to improving the transfer of training are summarized here. I have included examples of specific activities that can be undertaken to satisfy each element.

Procedures
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
say how to perform and why update relevant policies and procedures before training begins

use actual policy and procedural documents during training

Roles & Responsibilities say what level of performance is required cl
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
rify role responsibilities and update relevant role descriptions
link learning outcomes to role descriptions

Aids on the job extend the training room into the workplace replicate training aids on the job

encourage employees
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to use on-the-job aids

Coaching overcomes individual barriers to skill application plan for and dedicate on-the-job coaching resources

train coaches in how to coach effectively

Targets and measurem
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
nt proves people are performing agree and set measurable organizational and individual goals

link program learning outcomes to organizational and individual goals

translate goals into required on-the-job behaviors

Incentives
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
give a personal reason to perform modify incentives to reward goal achievement and expected behaviors

provide employee feedback frequently and using a variety of methods

Communication informs and involves all stakeholders
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
li>communicate information to all appropriate levels in organization
use a variety of communication mediums and styles

Engagement motivates participants to apply skills brief employees before training on purpose and application of p
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
rogram
managers and supervisors introduce training and attend sessions

review learning after training and identify opportunities for skill application

follow up regularly progress on skill application with employee

After you complete the tra
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ning program, you will want to determine the extent of training transfer. Observe participants in the workplace or survey participants and their managers to find out how much they are using their newly learned skills on the job. Feedback the results to managers and use the learnings to im
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
rove your program further. You can even use the PRACTICE Approach © as the structure for your discussions with supervisors and managers on how best to work together to get the most benefit from your training programs.

2006 © Business Performance Pty Ltd. All rights reserved

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Advice You - Transfer of Training: How to Promote Skill Transfer in Your Organization

Related Articles: